In summary, our study revealed significantly shorter OS and CSS in patients with SATB2lo and CK7+ CRC and borderline insignificantly shorter OS in patients with PD-L1+ CRC in the neoadjuvant therapy-naïve and in the entire cohort. Here, KRT7 is linked to colorectal carcinoma.